Family Medicine · Glendale, CA
NPI
1043482060
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1030 S Glendale Ave Ste 200
Glendale, CA, 91205
Phone (818) 850-5667
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
3,366 services
Medicare patients, 2024
404
Average age 73
Drug cost, 2024
$1.4M
16,891 prescriptions
Company payments, 2025
$856
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antonio Zamorano was code 99214 (office e&m - established), 636 times for 208 patients. In total Antonio Zamorano billed 3,366 services in 55 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 636 | 208 | $99.43 | $63K |
| 99211 Office E&M - Established | Office | 549 | 168 | $18.36 | $10K |
| 36415 Venipuncture Blood Collection | Office | 235 | 84 | $8.65 | $2,033 |
| 99213 Office E&M - Established | Office | 180 | 80 | $71.93 | $13K |
| 82962 Clinical Chemistry | Office | 144 | 53 | $3.21 | $462 |
| 99223 Hospital E&M - Initial | Facility | 143 | 140 | $131.16 | $19K |
| 99442 Telephone Services | Office | 118 | 77 | $49.08 | $5,791 |
| 96372 Injection Administration | Office | 63 | 26 | $12.58 | $793 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 57 | 31 | $13.70 | $781 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 49 | 49 | $140.22 | $6,871 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 38 | 14 | $0.52 | $19.77 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 33 | 26 | $167.14 | $5,516 |
| 99443 Telephone Services | Office | 25 | 20 | $65.86 | $1,646 |
| 99204 Office E&M - New | Office | 16 | 16 | $124.79 | $1,997 |
| 93000 Electrocardiogram | Office | 14 | 14 | $11.65 | $163 |
By year: 2022 $127K for 1,730 services; 2023 $149K for 5,543 services; 2024 $143K for 3,366 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 235 | 84 | $8.65 | $2,033 |
| 82962 Clinical Chemistry | 144 | 53 | $3.21 | $462 |
Medicare prescription drug claims, 2024
In 2024, the drug Antonio Zamorano prescribed most often to Medicare patients was Atorvastatin Calcium, with 865 prescriptions and refills. In total Antonio Zamorano wrote 16,891 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 865 | 1,935 | 268 | $7,717 |
| Metformin Hcl Generic | 839 | 1,896 | 247 | $7,043 |
| Amlodipine Besylate Generic | 655 | 1,433 | 184 | $3,212 |
| Losartan Potassium Generic | 636 | 1,529 | 187 | $8,166 |
| Levothyroxine Sodium Generic | 454 | 1,133 | 129 | $9,243 |
| Omeprazole Generic | 432 | 899 | 139 | $4,937 |
| Lisinopril Generic | 411 | 967 | 121 | $3,225 |
| Ibuprofen Generic | 376 | 410 | 158 | $2,533 |
| Gabapentin Generic | 343 | 544 | 92 | $4,317 |
| Tamsulosin Hcl Generic | 320 | 700 | 108 | $4,761 |
| Duloxetine Hcl Generic | 293 | 404 | 67 | $3,007 |
| Simvastatin Generic | 243 | 588 | 86 | $2,782 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 226 | 226 | 35 | $2,436 |
| Famotidine Generic | 216 | 386 | 67 | $1,656 |
| Diclofenac Sodium Generic | 211 | 233 | 59 | $93K |
Brand drugs: 2,030 claims; generic drugs: 14,535 claims; opioid claims: 415.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antonio Zamorano $856 ($856 in general payments such as food, travel and fees) from 17 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $72.6 |
| Pfizer Inc. PFE | 3 | $69.08 |
| GlaxoSmithKline, LLC. GSK | 2 | $56.13 |
| Novo Nordisk Inc NVO | 3 | $54.34 |
| Amgen Inc. AMGN | 2 | $46.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $44.32 |
| Boston Scientific Corporation BSX | 1 | $43.4 |
| Exact Sciences Corporation EXAS | 1 | $33.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.